Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Trial of Pharmacological Ascorbate With Concurrent Chemotherapy and Radiation Therapy for Non-small Cell Lung Cancer

NCT02905591 is registered in ClinicalTrials.gov with Joseph J. Cullen, MD, FACS as lead sponsor.

NCT NCT02905591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02905591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Trial of Pharmacological Ascorbate With Concurrent Chemotherapy and Radiation Therapy for Non-small Cell Lung Cancer
Lead sponsor
Joseph J. Cullen, MD, FACS
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 16, 2018
Completion date
December 31, 2027
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, non-small cell lung cancer, non-small-cell lung carcinoma, nonsmall cell lung cancer, nsclc